Every January, millions of people start the new year vowing to lose weight. But in 2025, many of those hoping to shed the ...

New Alzheimer's disease drugs, a world-first skin cancer vaccine, and personalised health apps that change the way we track ...

Ozempic, a brand name for semaglutide, has gained significant attention in the medical community and among patients for its ...

If the stroke is hemorrhagic (bleeding in the brain), treatment is usually surgical and depends on how much you are bleeding and the location of the hemorrhagic ... has increased above 70 mg/dL.

Both semaglutide and tirzepatide are glucagon-like peptide-1 (GLP-1 ... whole genome sequencing technology to look at every location in the 3 billion letter genome, enabling the identification ...

Objective—Glucagon-like peptide 1 (GLP-1) exerts beneficial antidiabetic actions via effects on pancreatic β- and α-cells. Previous studies have focused on the improvements in β-cell function ...

Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, today announced ...

On the other hand, when your blood sugar levels drop too low, your pancreas releases the hormone glucagon, which raises your blood sugar levels. Some people, such as those with diabetes ...

Musk, suggesting a solution, stated that making Glucagon-like peptide-1 (GLP-1) inhibitors affordable for Americans in need could help lower healthcare costs and improve overall health.

Mounjaro is a prescription glucagon-like peptide-1 (GLP-1) drug with the active ingredient tirzepatide. Doctors prescribe it for the treatment of type 2 diabetes, but they may also prescribe it ...

Drugs like Ozempic and Wegovy are part of a class of medications called glucagon-like peptide-1 agonists, or GLP-1 agonists, which mimic the GLP-1 hormone in the body that controls insulin and ...